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Abstract. Policy makers are becoming increasingly aware of the fact that R&D inten-
sive SMEs play a pivotal role in providing sustainable economic growth by maintain-
ing a high rate of innovation. To compensate for their financial vulnerability, these 
SMEs increasingly conduct innovation in alliances. This paper aims to explore the 
impact of different alliance characteristics on the performance of Dutch biotechnology 
SMEs. The conceptual model was tested using a sample of 18 biotech SMEs reporting 
about 40 alliances. The main findings indicate that alliance performance is positively 
related to the level of complementarity, the cognitive distance and tacit knowledge 
transfer by the human resources exchanges. Policy makers are recommended to sup-
port innovation alliances by providing the infrastructure in which alliances can flour-
ish, e.g. through stimulating the foundation of cluster organizations that can function 
as innovation brokers. These cluster organizations can provide network formation, 
demand articulation, internationalization and innovation process support to their 
member companies and can act as a go-between among alliance partners. As part of 
the innovation process support activities, they can organize special workshops for bio-
tech SMEs on how to successfully behave in an innovation alliance.
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JEL Codes. O32
1. Introduction
Policy makers are becoming increasingly aware of the fact that R&D intensive SMEs 
play a pivotal role in providing sustainable economic growth by maintaining high innova-
tion rates. To compensate for their financial vulnerability, these SMEs increasingly con-
duct innovation in alliances. A good understanding of the mechanisms that govern such 
innovation alliances is therefore a prerequisite for an effective innovation policy. 
This paper aims at contributing to our understanding of the dynamics of innovation 
alliances by exploring the impact of different alliance characteristics on the performance 
of Dutch biotechnology SMEs. An R&D intensive biotech SME is often the product of an 
innovative idea; an ad-hoc creation triggered by the presence of a “star scientist” (Zucker 
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and Darby, 1997), following a high-risk strategy that involves cutting edge science (Pisano, 
2006). Hall and Bagchi-Sen (2002) found in their sample of 74 biotech companies in Can-
ada (95% SMEs) that 28% of the companies originated from universities and 15% were 
industrial spin-offs, whereas more than 50% was founded as independent ventures (Hall 
and Bagchi-Sen, 2002). 
Small biotechnology companies are frequently facing resources constraints (Majewski, 
1998). Considerable capital investments are needed to pay for specialized staff and equip-
ment to develop new products and processes and to successfully introduce them to the 
market. This problem is even more pressing because biotechnology companies, especial-
ly those related to the health sector, face long time horizons until first revenues begin to 
pour in, which often makes them not profitable for a long period of time (Denis, 2004). 
Bagchi-Sen (2002) mentions the following barriers to innovation: lack of skilled manag-
ers or researchers, a lack of physical facilities for research or manufacture, as well as a lack 
of marketing or distribution channels. Biotechnology firms may suffer from resource con-
straints, but at the same time they generally have a lower bureaucratic burden. They are 
usually considered to be more flexible and therefore better innovators. Unique compe-
tencies, a low level of hierarchy and a high internal flexibility (Nooteboom, 1994, Pisano, 
2006) make up for their lower financial power (Argyres and Liebeskind, 2002). A general 
overview of the advantages and disadvantages of SMEs, not limited to the biotech sector, 
is provided in the literature review of Ale-Ebrahim et al. (2010), while Khilij et al. (2006) 
conducted exploratory research specifically on the challenges of biotech SMEs.
Mangematin et al. (2003) found in their study of 60 French biotech SMEs, an aver-
age growth rate of 30% in turnover and 13% in staff. Still, only a small number of biotech 
firms grow into reasonably large companies, especially those companies that have learned 
to engage in collaboration projects with a heterogeneous set of partners (Powell et al., 
2005). The forming of alliances as an effective tool to overcome the problems of limited 
resources was also found in a study of Rothaermel and Deeds (2004) on 325 health relat-
ed biotechnology companies. Strategic alliances constitute a powerful strategy for biotech 
firms to overcome their capital constraints (Khilji et al., 2006) and are found to accelerate 
innovation (Terziovski and Morgan, 2006). Alliances allow access to missing competences 
and material resources and thus enhance the innovative potential and firm performance 
(Hall and Bagchi-Sen, 2002, 2007). However, Khilji et al. (2006) indicate that not enough 
is known on how to successfully manage a strategic alliance. Pisano (2006) criticizes that 
business models, organizational strategies and approaches from other high-tech sectors 
have been used while not taking into account the special characteristics of the biotech sec-
tor, and that organizational and institutional innovations are needed to unlock the potential 
of biotechnology (Pisano, 2006:202).
The high level of innovativeness of the biotech sector, combined with the high level of 
alliance formation makes it an ideal sector to study the critical success factors for collabo-
rative ‘open’ (Chesborough, 2006) innovation. To date, a number of empirical studies have 
been carried out to study alliance collaboration in this sector. They focus on the company 
performance related to the alliance portfolio (see Baum et al., 2000; George et al., 2001), 
the network composition and dynamics (Gay and Dousset, 2005), or the alliance dura-
tion in an uncertain environment (Pangarkar, 2003). The alliance collaboration process 
concerning knowledge management (i.e. Nooteboom et al., 2007, Standing et al., 2008), 
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alliance capabilities (Heimeriks and Duysters, 2007) and governance (Phene and Tallman, 
2012) are also the focus of more recent studies. However, a literature review (not only on 
biotech alliances) done by Comi and Eppler (2009), is still highlighted a lack of research 
on alliance management, especially in startup biotech companies.
The objective of the present paper is to fill this gap by studying the alliance collabora-
tion process to explore the attributes of both successful and less successful innovation alli-
ances among biotech SMEs. This will allow the improvement of policy support focusing 
on alliance collaboration process. To this end, different types of alliances, that were set up 
to carry out joint open innovation projects (in the remainder of this paper termed ‘inno-
vation alliances’), are investigated and their effect on the alliance potential, alliance execu-
tion and the alliance performance is mapped.
The remainder of this paper is organized as follows: Section 2 contains the Theoretical 
framework. In this section the discussion of the Resource Based View (RBV) will lead to 
the conceptual model in which the concepts relevant for this research and their relation-
ships are identified. At the beginning of Section 3, Research methodology, the operationali-
zation of the constructs is presented. Section 3 also discusses the methods of data collec-
tion and data analysis. Section 4, Results, starts with the baseline description of the par-
ticipating companies and their alliances. Next, the results are analyzed using partial least 
squares, while comparing the theoretically expected results with the empirically model. In 
Section 5, Conclusions and Discussion, the main conclusions are drawn, and suggestions 
for further research are given and recommendations for practitioners and policy makers 
are provided. 
2. Theoretical framework
In management literature it has been argued that strategic technology partnering 
can induce the effective use of heterogenic resources (Hagedoorn, 1993; Powell et al., 
1996; Ahuja, 2000; Rowley et al. 2000; Rosenkopf & Almeida, 2003). A better under-
standing of this phenomenon is achieved by application of the RBV (Barney, 1991, 
Alegre et al., 2011). RBV is based on two fundamental assumptions: companies in an 
industry do not all possess the same resources which provides resource heterogeneity, 
whereas the partial immobility of these resources preserves this state of disequilibrium 
(Barney, 1991). Following the line of thought of the RBV, an alliance is a tool to (partly) 
overcome the problem of the immobility of resources by creating a new entity with a 
unique set of resources. Nooteboom et al., (2007) claims that while the antecedents of 
resource heterogeneity and the consequences for the firm’s innovation performance have 
been studied, the direct effects on the innovation process have largely been ignored. 
Nooteboom et al. fills this gap by shedding light on the causal factors underlying the 
inter-firm learning process, especially with regard to the cognitive distance between 
firms. Our study aims at taking Nooteboom et al.’s important conceptual idea a step 
further, by looking at alliance formation and execution from a process perspective. We 
do this by modeling the collaborative open innovation process for which the alliance is 
set up: from the potential of the alliance for the participating companies via the alliance 
execution to the final alliance performance. 
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2.1 Conceptual Model
The model developed for the present study conceptualizes the alliance as a collabora-
tive entity created by two or more companies in order to innovate. Several factors that are 
expected to play a role in the innovation alliance collaboration process have been identi-
fied. These factors and their assumed relationships are presented in the conceptual model 
in Figure 1. The different constructs are discussed in more detail in the following sections.
Figure 1: Conceptual model
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2.2 Alliance Potential
In the phase preceding the actual start of an alliance, potential partners have to be 
identified. Each potential partner has not only its own distinct set of material and imma-
terial resources, but also a different expectation of what it might gain from the alliance. 
The decisions made in the selection process set the stage for the alliance, and determine 
the alliance potential. We identified the following factors as determinants for the alliance 
potential: Level of complementarity, Cognitive distance and Alliance importance. 
2.2.1 Level of Complementarity and Cognitive Distance 
Each potential partner has its own distinct set of material and immaterial resources. 
The decision has to be made whether to search for partners with similar or complimen-
tary resources. By combining similar resources, realizing economies of scale and scope 
can be expected (Ansoff, 1965; Montgomery, 1985), whereas an alliance with a partner 
that has complementary resources synergy effects might be obtained (Harrison et al., 
2001). According to RBV, alliances can be considered as tools to create new unique sets 
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of resources that enable the partnering firms to (partly) overcome the immobility problem 
of certain resources. We therefore assume that the potential of an alliance will be posi-
tively influenced by the level of complementarity of the resources that are brought into 
the alliance by the partnering companies and the extent to which these are exchanged. 
Complementary resources deliver learning opportunities and allow the creation of new 
capabilities (Harrison et al., 2001). Besides its importance in acquisitions Harrison et al. 
(2001) proved complementary resources to play a major positive role in strategic allianc-
es. Chesbrough (2006) also stresses the importance of complementary resources for open 
innovation projects. So, with the choice of partners, the focal company determines how 
far its material and immaterial resources will be complimented by those of the partner(s). 
However, the level of complementarity alone is not enough. Selecting partners with com-
plementary resources only makes sense if the partners are able to understand each other’s 
knowledge contribution. Indeed, Park and Russo (1996) found that joint ventures that 
used complementary resources failed more often than what was expected. An explanation 
for this finding might be found in the work of Cohen and Levinthal (1990), who point 
at the importance of absorptive capacity; defined as a company’s capability to recognize 
the value of new information, its ability to assimilate it and to apply it to commercial 
ends. Absorptive capacity is dependent on information redundancy or as Nonaka (1994: 
29) states: ‘ Only individuals sharing overlapping information can sense what the others are 
trying to articulate’ . It is therefore expected that when the research domains of the part-
ners and the range and methods used (termed ‘ cognitive distance’ by Nooteboom, 2000) 
are too far apart, the level of absorptive capacity will decrease and with this the synergy 
potential of the alliance. Indeed Nooteboom et al. (2007) found that there is an optimum 
cognitive distance in alliances.
2.2.2 Alliance importance
Next to the distinct material and immaterial resources that partners bring into an alli-
ance, their intentions and motivation to turn the alliance into a success are expected to 
play an important role. The more partners who expect to benefit from the alliance, the 
more they are likely to be motivated and willing to invest in it. This factor is termed ‘alli-
ance importance’. It is expected that a high level of importance attached to the alliance will 
positively correlate with alliance performance. 
2.3 Alliance Execution
During the alliance execution phase knowledge is transferred and utilized to develop 
new products and processes. The following factors were identified as essential elements 
to characterize the quality of project execution: knowledge transfer, technology mapping, 
outsourcing, governance mechanisms and alliance compliance. 
2.3.1 Knowledge transfer
According to Nooteboom (2000, p. 70) knowledge transfer between the alliance part-
ners in all its complexity is the core of every innovation alliance. Knowledge transfer deals 
with the challenge of two or more companies acting on a chosen task as one entity, as 
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a sense making system (Weick, 1995; Choo, 1998). Nonaka (1994) identifies two forms 
of knowledge: explicit and tacit knowledge, and four ways in which knowledge can be 
transferred: from explicit to explicit, from explicit to tacit, from tacit to explicit, and from 
tacit to tacit. Where explicit knowledge is stored in codified form and can be transferred 
through documents, tacit knowledge requires human interaction to transfer i.e. through 
shared experience (Nonaka, 1994). Nonaka and van Krogh (2009) therefore recommend 
human resource exchange as an effective way to transfer knowledge because it implies a 
flow of information comprising of both tacit and explicit knowledge. It allows for all four 
forms of knowledge transfer by creating a mutual understanding including social practices 
and enables the transformation of resources from both alliance partners into something 
new. Also mutual support in terms of management, coaching and training is assumed to 
lead to knowledge transfer between the alliance partners.
2.3.2 Alliance compliance
Low alliance compliance is a factor that can crush the expectations resulting from 
the alliance potential assessment. Issues like trust and cooperation within high tech alli-
ances are found to be positively related to human resource exchange practices (Collins 
and Smith, 2006). The level to which partners adhere to the agreements made before the 
actual start of the innovation alliance (termed ‘alliance compliance’) is expected to play 
an important role by creating the trust and spirit of cooperation necessary for the smooth 
execution of the collaborative open innovation project. If there is no compliance because 
of mistrust due to opportunism, missing coordination of company actions knowledge 
transfer might be lowered. In a company collaboration context this also means that the 
process of transforming tacit into explicit knowledge slows down or even stops. 
2.3.3 Governance mechanisms
Nooteboom (2000) provides a literature review on the problems in governing knowl-
edge transfer. He lists notion of “hostages”, redistribution of ownership of specific invest-
ments, balance of mutual dependence, and reputation mechanisms as possible governance 
mechanisms to deal with these problems. In this paper, we focus on technology mapping, 
with mutual dependence, and outsourcing of certain innovation activities which encom-
passes the (re) distribution of ownership. The notions of hostages and reputation mecha-
nism were not included in the present paper, since no trustworthy quantitative data could 
be collected, due to socially desired answers. Here an observatory approach is suggested 
for further research.
2.3.4 Technology mapping
Intellectual Property (IP) is important in alliances in which the partners work closely 
together to reach certain innovation aims and objectives. IP management is connected to 
terms like, IP valuation, IP licensing, IP preparation for sale, detection of infringements, 
and use of IP intermediate markets (Chesbrough, 2006). To secure the ownership of IP 
after a completed discovery is a big issue and is becoming even more challenging in the 
world of open innovation, where “technologies flow across the boundary of the firm” (per-
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haps multiple times) and where “obtaining the ability to practise a technology without 
incurring an infringement action by another firm is more challenging because the full history 
of the technology development is well known” (Chesbrough, 2006, p. 67).
Patents are often used to protect knowledge from being stolen, provide a possibility to 
legally own it and make it tradable. Patents also indicate the value as a network partner as 
shown by the research of Smith-Doerr et al. (1999) on biotechnology firms.
Patents reduce the risk of infringement but only if all of the knowledge used in the 
technology application is included in that patent, or possibly in several patents. So to pre-
vent infringements patent mapping is unavoidable. Patent mapping checks for all of the 
granted claims of a patent that is owned by the company and looks also at possible claims 
that could arise from other patent holders (Chesbrough, 2006). This might lead to efforts 
to obtain possession of patents that are holding key positions in the innovation process of 
the company or the alliance. In order to reduce the risk of exploring without being able 
to exploit, one should think of starting patent mapping already early in the innovation 
process. This reduces the risk of being left with a discovery at the end of the innovation 
process that cannot be exploited. In an innovation alliance there is also the possibility that 
the alliance partners look at each other’s patents in order to investigate their potential. In 
a study about Canadian biotechnology start-ups, Baum et al. (2000) found alliances that 
provide access to more diverse information and capabilities per alliance … will prove most 
beneficial to startups. So resources exchange in the form of IP may be enhanced by let-
ting the alliance partner having a closer look at the patents in store or at technologies 
with no patents or no patents granted yet. This is also the reason that we prefer to use the 
term technology mapping in this paper. We extend the meaning beyond the IP protection 
aspect and focus also on using it as an alliance internal communication tool, and conse-
quently, also as a governance mechanism to transfer knowledge. By mapping the differ-
ent technologies used in an alliance in a shared document, explicit knowledge as well as 
redundancies are created. This will help to understand each other’s knowledge domains 
(e.g. Nooteboom, 2000) and since tacit knowledge is turned into explicit knowledge, alli-
ance coordination is simplified. 
2.3.5 Outsourcing
Complementary resources possess the potential to enhance synergy. In cases where 
knowledge is easy to transfer this process is straight forward. However, in cases where 
the complexity of matching complementarity resources is high, this could lead to hold 
up (Nooteboom, 2000). The way to synergy creation might then go via direct outsourc-
ing of activities to the alliance partner without much direct contact lowering coordination 
costs. However outsourcing also demands knowledge transfer in order to determine which 
activities are to be outsourced and in what way the outsourcing process will be set up.
2.4 Alliance Performance
In industry, performance can be assessed at the innovation process level (innovative 
performance) and at the industrial outcome level (industrial performance, Omta and de 
Leeuw, 1997). Since the research process takes place within an alliance we are looking at 
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the innovative performance at the alliance level. Alliance performance in our paper there-
fore focuses on the output resulting from the collaboration. Next to the direct results in 
terms of new products and processes, this could be new contacts, a better reputation within 
a network, or a new line of thinking. All of these outcomes may lead to a higher potential 
of future alliances with current or other partners and therefore demands a dynamic model. 
However, for the present paper, the choice was made to look at the alliance at one point 
in time. Therefore the output focus lies on the synergy created and in how far the alliance 
resulted in new knowledge (inventions) and new products and processes (innovations).
2.4.1 Alliance synergy
Synergy describes a situation where the final outcome of a system is bigger than the 
sum of its parts. This can be found in an alliance in the form of new knowledge that sur-
mounts the knowledge input that was brought into the alliance from both alliance sides as 
well as to new processes and technologies resulting from the alliance.
2.4.2 Exploration and Exploitation performance
Alliance performance covers exploitation performance and exploration performance, 
where exploitation is concerned with the refinement and extension of existing technolo-
gies (Lavie and Rosenkopf, 2006) and exploration is rooted in the extensive search for 
potential new knowledge (March, 1991). 
The theory leads to the following general hypothesis: Innovation alliances that show a 
higher level of complementarity and overcome cognitive distance with intense knowledge trans-
fer lead to the creation of synergy and ultimately to a higher level of innovation performance.
3. Research methods
For this study a sample was composed of firms active in the Dutch biotechnology sec-
tor. Eighteen SMEs participated in the study, reporting about 40 alliances. For the empiri-
cal test of the model a two-step approach was chosen. Firstly the constructs used in the 
model were operationalized. Then the respondents were given the survey to answer the 
indicator questions on a Likert scale of 1 (“not at all”) to 7 (“to a very large extent”). The 
detailed items used to measure each construct are listed in Table 1.
Partial Least Squares (PLS) software ( Ringle et al., 2005) was used to model the alliance 
collaboration process and to test the main hypothesis. PLS delivers construct scores, i.e. proxies 
of the constructs, which are measured by one or several indicators (Henseler et al., 2009:283). 
PLS is a causal modeling approach, developed by Wold in 1975 and applicable in strategic 
management research (Hulland, 1999). PLS is similar to regression, but simultaneously models 
the structural path (i.e. theoretical relationship among constructs) and the measurement path 
(i.e. relationship between a construct and its indicators, Chin et al., 2003, p. 25). 
The procedure enables the modelling of constructs and gives more accurate estimates 
of interaction effects between constructs, as it takes the measuring errors in the underly-
ing indicators into account.
PLS shows the significant effects of the different constructs on each other, while every 
construct itself is reflected by its indicators (measures). With the help of PLS (a series of 
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ordinary least squares) the constructs are estimated as linear combinations of its measures, 
by maximizing the explained variance for the indicators and the constructs. As a result the 
construct is not only maximally correlated with its own set of indicators, but also with the 
other constructs, according to the structure of the PLS model (Chin et al., 2003). Although 
Table 1. Operationalization of constructs
Level Construct Convergent validity
Cross
Loading
Indicator Questions  
(Likert scales from 1 to 7 are employed)
A
lli
an
ce
 P
ot
en
tia
l
Level of complementarity 0.94
0.95
0.94
To what extent are there complementary 
resources in this alliance.
The exchange of resources in this alliance 
is important.
Cognitive distance 0.89
0.85
0.87
0.86
To what extent does the expertise your 
company posses differ from your alliance 
partner?
To what extent does the research field 
your company operates in differ from your 
alliance partner?
To what extent are the patents you posses 
located in a different research field?
Alliance importance Number of staff of your company involved in the alliance
A
lli
an
ce
 E
xe
cu
tio
n
Knowledge transfer 0.81
0.73
0.81
0.78
This alliance partner supports in 
management coaching and training. 
This alliance partner exchanges human 
resources with you.
The exchange of human resources in this 
alliance is important.
Alliance compliance 0.85
0.91
0.81
In this alliance opportunism occurred to be 
a problem.
In this alliance coordination occurred to be 
a problem.
(Both rescaled to 7= ” not at all “down to 
1= ” extremely high amount of ”)
Governance 
mechanisms
Outsourcing 0.83
0.90
0.79
Activities outsourced to the partner due to 
restrictions of company apparatus.
Activities outsourced to the partner due to 
restrictions of company skills.
Technology 
mapping
Extent of technology mapping used in this 
alliance.
A
lli
an
ce
 P
er
fo
rm
an
ce Alliance synergy
Please give the synergy created due to this 
alliance.
Exploration performance Due to this cooperation new knowledge was generated.
Exploitation performance 0.83
0.91
0.78
Due to this alliance products were 
developed, that were new to the market.
Due to this alliance production processes 
were created or significantly improved.
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Partial Least Squares (PLS) can be used for theory confirmation, it can also be used to suggest 
where relationships might or might not exist and to suggest propositions for later testing (Chin 
and Newsted, 1999:313). Marcoulides and Saunders (2006) warn researchers not to use PLS 
as a “silver bullet” while Hair et al. (2011) specify under which conditions PLS is indeed a 
silver bullet. For the decision to apply PLS, the scaling, the number of cases and distribu-
tion of the data had to be taken into consideration. In contrast to LISREL, PLS can deal 
with small sample sizes as small as 20, depending on the complexity of the model and the 
size of the effects to be detected (Chin and Newsted, 1999), and doesn’t require a normal 
distribution of the data (Chin et al., 2003). With 40 alliances, in the present study the nec-
essary condition that the number of cases at least exceeds the number of indicators (Haen-
lein and Kaplan, 2004) was reached. The significances of the interaction effects uncovered 
with PLS were tested with Bootstrapping. Bootstrapping is a cross-validation method. It is a 
resampling procedure, which yields the same number of cases as in the original sample. As 
the bootstrapping is based on trial and error it gives slightly different results every time it 
is used for the same model, which differ even more from each other, the smaller the num-
ber of resamples. The number of resamples was chosen to be 1000 exceeding the 200 indi-
cated as minimum by Chatelin et al. (2002). The Kolmogorov Smirnov Z test was used for 
finding differences between pharmaceutical related and agrifood related alliances and the 
Kruskal Wallis exact test was used to identify mean differences between the alliances stated 
by different companies of different size and location categories.
4. Results
4.1 Baseline description
The hypothesis was tested analyzing 40 alliances of 18 SMEs in the Dutch biotech-
nology sector. Of the companies that answered the questionnaire, 6 have business activ-
ities in diagnostics, 6 in therapeutics, 3 in food and neutraceuticals and 6 in plants and 
seeds biotechnology. The majority of the SMEs are product oriented, with products such as 
biomarkers for cancer treatment, but also microbiological products related to food safety 
and breeding. Fourteen SMEs are located in different clusters or cluster like set-ups, such 
as incubator centers, university campuses or business parks (see Table 2), while 4 compa-
nies are not connected to a company agglomeration. The cluster or cluster like set-ups are 
spread all over the Netherlands2. They are frequently headed by a coordinating organiza-
2 The Leiden Bioscience Park (www.leidenbiosciencepark.nl) around Leiden University includes more than 70 
member companies, the Science Park Amsterdam (www.scienceparkamsterdam.nl) around the University of 
Amsterdam and the ‘Vrije’ University of Amsterdam consists of around 70 companies, and Science Park Utrecht 
(www.utrechtsciencepark.nl) around the University of Utrecht, more than 60 companies. In the North of the 
Netherlands we find Seed Valley: (www.seedvalley.nl) a cluster of 22 breeding companies, located at one of the 
world’s largest plant breeding areas. The Food Valley cluster, around Wageningen University, is coordinated by 
Food Valley Organization (www.foodvalley.nl) and has more than 100 member companies. About 30 km to the 
South is the core of the HealthValley cluster (www.health-valley.nl), which is located around Radboud University 
Nijmegen, with around 100 member companies. In Eindhoven, located in the South East of the Netherlands, lies 
the high-tech campus of the University Eindhoven (www.tue.nl) with 108 companies located on it. Further to 
the East on the German border we find the BioPartner Center Maastricht (www.bpcm.nl) located on the Health 
Campus of the University of Maastricht with 22 companies.
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tion, and financed by membership fees of the participating companies and/or public mon-
ey. These coordinating organizations provide network formation, demand articulation, 
internationalization and innovation process support (Omta and Fortuin, 2011). They do 
so by organizing consortium meetings and annual conferences, providing matchmaking 
opportunities for member companies (network formation support), issuing (web-based) 
innovation alerts and providing information about marketing trends (demand articulation 
support), representing the member companies at international fairs and organizing busi-
ness missions (internationalization support), and stimulating facility sharing and organiz-
ing of special workshops to enhance innovation management (innovation process support).
The SMEs organized in science parks or university campuses indicated possessing 
the highest alliances performance levels. SMEs not related to bioscience parks or clusters 
described fewer complementary resources, fewer synergistic effects, and used outsourc-
ing to a lesser extent. Furthermore, they allocated a smaller level of relative importance 
to resource exchange, and especially to human resources exchange. Their alliance perfor-
mance levels were lower compared to the other alliances in our study, although they indi-
cated they faced opportunism problems to a lesser extent.
Table 2. Demographics of SMEs (n=18) and their alliances (n=40) in the present study.
SME Alliances
Bioscience park, university campus* 7 16
Clusters** 7 15
Not related to bioscience parks or clusters 4 9
18 40
* Leiden Bioscience Park, Utrecht Science Park, Amsterdam Science Park, Maastricht Biopartner Center, 
Eindhoven TU 
** Food Valley, Health Valley, Seed Valley
Eleven companies employ 2 to10 full time employees, while six companies employ 
10 to 30 employees, and one company even has 113 employees. Mangematin et al. (2003) 
found differences in their study on 60 French biotech SMEs between the slightly smaller 
SMEs (around 10 employees) with small innovation projects targeting niche markets and 
the slightly bigger SMEs (around 30 employees), which focused on radical innovation pro-
jects and grew faster than the first type (Mangematin et al., 2003). Also in our study we 
found a number of differences related to the size of the company. The companies with 10 
to 30 employees indicated a higher number of staff involved per alliance, older alliances, 
used technology mapping to a lesser extent and stated—probably because of the more rad-
ical nature of the technology involved—a lower alliance performance level, compared to 
the smaller firms and the very big firm. 
The 40 alliances which are the focus of our analysis are split into 26 health-related 
alliances in 12 companies, and 14 agrifood related alliances between 6 companies. The 
most important alliance partners were knowledge institutions (in 40% of the cases), big 
pharmaceutical and chemical trusts (in 15%), other biotech SMEs (in 18%), and non-bio-
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tech firms, such as manufacturers (in the 27% of the cases). The sample is dominated by 
research consortiums and strategic alliances but also includes two informal partnerships. 
As primary reasons for strating the alliance, increasing innovation and the use of com-
plementary technologies was mentioned most often, followed by the increased access to 
funding and markets. Thirty of the 40 alliances involved 1 to 3 persons from the compa-
nies that answered the questionnaire. In 8 alliances, 3 to 10 persons were involved and in 
two alliances the number of employees involved was not given. In 30% of the alliances 
more than 2 companies were involved. The ages of the alliances were equally distribut-
ed from 1 to 7 years. There were some differences between the groups of health-related 
and agrifood-related alliances that were able to be uncovered by using the Kolmogorov-
Smirnov Z test. Among the health-related alliances, more technology was licensed out 
to the alliance partner(s), and a smaller cognitive distance characterized these alliances. 
The agrifood related alliances scored higher when it came to complementary resources 
and also with regard to the number of new products or processes that were created and 
improved in the alliance.
4.2 The measurement model
Hulland (1999) suggested a general methodology for applying PLS on management 
issues. First, the reliability and validity of the measurement model has to be assessed 
before the structural model can be examined and path coefficients interpreted (Hulland 
1999: 198). The measurement model consists of the constructs and the indicators connect-
ed to them. Its reliability and validity is assured by verifying individual item reliability, the 
convergent validity of measures associated with the individual constructs, and the discri-
minant validity.
To measure individual item reliability, the cross-loadings between the indicators and 
the constructs were checked. Every indicator should, in relation to its construct, have a 
cross loading higher than 0.7, and indicators to which constructs are not connected 
should never receive high cross-loadings than those to which they are (Hulland, 1999). 
The cross-loadings of the indicators generated here fulfill these requirements (Table 1).
To assess the convergent validity of the measurement model a choice can be made 
between Cronbach’s alpha and the Composite Reliability, as developed by Fornell and 
Larcker (1981). Nunnally (1978) suggests 0.7 as a benchmark and according to Hulland 
(1999) it can be used as a cut-off point for both measures. As Cronbach’s alpha tends 
to underestimate the internal consistency in PLS path models (Hensler et al., 2009), the 
Composite Reliability was used to measure the convergent validity of the constructs in 
this paper. These were all above 0.7 (Table 1).
The traditional methodological complement to convergent validity is discriminant validi-
ty, which represents the extent to which measures of a construct differ from measures of other 
constructs in the same model (Hulland 1999:199). By making use of the variance the con-
struct shares with its indicators, compared to the variance it shares with the other con-
structs, the discriminant validity can be assessed by using the AVE (i.e., the average vari-
ance shared between a construct and its measures). The square root of the AVE should be 
higher than the construct correlations. Table 3 shows that this requirement is also met.
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Table 3. Construct Correlations
  1 2 3 4 5 6 7 8 9 10 Sqrt AVE AVE
1 Alliance compliance 1 0.86 0.74
2 Alliance importance -0.20 1 1 1
3 Cognitive distance -0.03 -0.11 1 0.86 0.74
 4 Exploitation performance -0.21 0 -0.11 1 0.84 0.71
 5 Exploration performance -0.13 0.19 0.28 0.25 1 1 1
 6 Knowledge transfer 0.15 0.37 0.26 -0.18 0.56 1 0.77 0.59
7 Level of complementarity -0.36 0.1 0.07 0.23 0.48 0.29 1 0.94 0.89
8 Outsourcing -0.13 0.22 -0.12 0.31 0.38 0.41 0.22 1 0.85 0.72
9 Alliance synergy -0.23 -0.14 0.06 0.48 0.56 0.02 0.68 0.34 1 1 1
10 Technology mapping -0.32 0.07 -0.53 0.51 -0.08 -0.37 0.19 0.14 0.29 1 1 1
Sqrt AVE 0.86 1 0.86 0.84 1 0.77 0.94 0.85 1 1  
4.3 The structural model
To what extent the path coefficient can be trusted depends on the significance level, 
verified by the t-values (Huber et al., 2007) that are generated with the bootstrapping pro-
cedure. For our model all path coefficients are significant at least at an α = 0.05 level. The 
significance of estimated coefficients in the structural model can be seen in the t-values of 
Table 4. The extent to which the endogenous constructs are explained by the exogenous 
constructs in the model can be determined on the basis of the R² values (displayed below 
in the text along with the equations derived from the model), wherein R² values of 0.67, 
0.33, and 0.19 (with regard to PLS path models) are seen as substantial, moderate, and 
weak, respectively (Chin 1998). Because the model was specified based on our hypotheses 
before the data were collected, the sample data were used to test the hypothesis only, and 
not to determine the structure of the model itself. Consequently there was no need for 
any further model validation (Kumar 2010). 
The following equations can be derived from the model: 
Knowledge transfer[R²=0.29] = 0.31*Cognitive distance + 0.46*Alliance importance + e1 
Alliance synergy[R²=0.50] = 0.64*Level of complementarity + 0.20* Outsourcing + e2 
Technology mapping[R²=0.41] = -0.46*Cognitive distance -0.28*Alliance compliance 
-0.21*Knowledge transfer + e3
Alliance compliance[R²=0.13] = - 0.36*Level of complementarity + e4
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Table 4. Significance of the estimated coefficients in the structural model 
 
Original 
predicted 
path 
coefficients
Sample 
Mean 
(bootstrap)
Standard 
Deviation 
(STDEV)
t-values
Alliance compliance -> Knowledge transfer 0,23 0,21 0,11 2,16*
Alliance compliance -> Technology mapping -0,28 -0,3 0,13 2,18*
Alliance importance -> Knowledge transfer 0,46 0,45 0,15 3,14**
Cognitive distance -> Knowledge transfer 0,31 0,33 0,12 2,49**
Cognitive distance -> Technology mapping -0,46 -0,46 0,15 3,15**
Knowledge transfer -> Exploration performance 0,54 0,55 0,1 5,43**
Knowledge transfer -> Outsourcing 0,41 0,43 0,14 2,89**
Knowledge transfer -> Technology mapping -0,21 -0,19 0,12 1,78*
Level of complementarity -> Alliance compliance -0,36 -0,38 0,1 3,5**
Level of complementarity -> Alliance synergy 0,64 0,63 0,11 5,97**
Outsourcing -> Alliance synergy 0,2 0,21 0,12 1,75*
Alliance synergy -> Exploitation performance 0,37 0,36 0,15 2,47**
Alliance synergy -> Exploration performance 0,55 0,55 0,08 6,72**
Technology mapping -> Exploitation performance 0,4 0,42 0,11 3,71**
*= significant with a likelihood of mistake of 5 percent one tailed
**= significant with a likelihood of mistake of 1 percent one tailed
Figure 2. PLS model for testing hypotheses with path coefficients
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Outsourcing[R²=0.17] = 0.41*Knowledge transfer + e5
Exploration performance[R²=0.61] = 0.54* Knowledge transfer + 0.55*Alliance synergy + e7
Exploitation performance[R²=0.38]= 0.40*Technology mapping + 0.37*Alliance synergy + e8
The hypothesis, Innovation alliances that show a higher level of complementarity and 
overcome cognitive distance with intense knowledge transfer lead to the creation of syner-
gy and ultimately to a higher level of innovation performance, holds true as the significant 
path coefficients in the Smart PLS model indicate.
The central role of Knowledge transfer predicated upon human resource exchange 
becomes visible through the model. The positive path coefficient from Cognitive distance 
leading to Knowledge transfer and from Knowledge transfer directly to Exploration perfor-
mance underscores that human resource exchange is the primary way of exchanging and 
converting both explicit and tacit knowledge.
What is further interesting to note is the significantly negative path coefficient from 
the Level of complementarity to Alliance compliance, which seems counterintuitive at first 
glance. However, if it is assumed that the value of the complementary resources of each 
alliance partner is not equally spread among the alliance partners and if unexpected high 
returns might turn up, one of the partners might decide to harvest them alone, leading to 
opportunism and a lower Alliance compliance. This explanation is supported by the fact 
that a moderately negative correlation of -0.30* was found from synergy created in the alli-
ance to no problems of opportunism in the alliance.
Other negative path coefficients are found from Alliance compliance to Technology 
mapping, from Cognitive distance to Technology mapping, and from Knowledge transfer to 
Technology mapping. This effectively translates into: in cases of low Alliance compliance, a 
small Cognitive distance and a low level of Knowledge transfer, a higher use of Technology 
mapping is also found. To explain the interdependence of these constructs, we can elabo-
rate the story which begins from a higher Level of complementarity and results in a lower 
level of Alliance compliance. To avoid opportunistic behavior, there is a clear need to put 
the technological contribution from each partner on paper, using technology mapping in 
order to create a common shared vision of this. The same holds in case of a smaller Cog-
nitive distance where it is even more likely that the partners doubt who is contributing 
what, and where concerns over becoming deprived of similar IP is higher than in alliances 
with a higher Cognitive distance, i.e., where the knowledge/IP contribution is clearer from 
the beginning. This conclusion was given further support by an interview with an R&D 
manager of a high-tech SME who indicated that technology and patent mapping was used 
only in interaction case of alliance partners with close cognitive distance. In cases of a low 
level of Knowledge transfer the higher level of Technology mapping can instead therefore 
be seen as a communication tool. The positive link between Knowledge transfer and Out-
sourcing suggests that there is a need to transfer knowledge first in order to determine an 
innovation locus based on the core competencies and facilities of the companies. Howev-
er, no significant positive link was found from Technology mapping to Outsourcing, which 
underlines the finding that the potential of Technology mapping as an alliance communi-
cation tool is often not exploited to full extent. When it comes to alliance performance, 
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the direct link from Knowledge transfer to Exploration performance stands in contrast to 
Exploitation performance, where Knowledge transfer—via Outsourcing—leads to Alliance 
Synergy, or—via Technology mapping—to Exploitation performance.
5. Conclusions and Discussion
The objective of the present study was to explore the attributes of alliances in the 
biotech industry in order to derive recommendations for how to improve policy support 
for SMEs in the open innovation process. It was hypothesized that innovation alliances 
that show a higher level of complementarity and deal with cognitive distance by inten-
sive knowledge transfer would show greater synergy creation, and ultimately a higher level 
of innovation performance. Our empirical findings in the Dutch biotech sector support 
this hypothesis. Our research also supports earlier findings that alliances allow for access 
to complementary resources (Ireland and Hitt, 1999) and that alliance companies often 
get close enough to each other in order to acquire tacit knowledge (Lane and Lubatkin, 
1998). Furthermore it was shown that, depending on the alliance potential, a differenti-
ated alliance execution process employing different governance mechanisms is required to 
achieve synergy and, in the end, a higher level of exploration and/or exploitation perfor-
mance. As hypothesized, both explicit and tacit knowledge transfer were demonstrated to 
be of central importance in the alliance execution phase. The level of knowledge exchange 
also determined which governance mechanisms were selected for the alliance. Knowl-
edge transfer has to be based on the exchange of human resources and an open informa-
tion flow in order to allow the exchange and conversion of tacit knowledge. We there-
fore conclude that mechanisms to enhance knowledge transfer, such as human resources 
exchange, deserve special attention in innovation alliances.
The level of knowledge transfer was found to suffer from a lack of clarity about the 
division of the alliance outcomes among the partners. This indicates that, first of all, it is 
of crucial importance to make good contractual arrangements prior to alliance execution 
(Tepic, 2012). A collaboration support tool, such as technology mapping, can then be used 
to create a common view on IP division among the partners and prevent the problem 
described by Shan (1990), i.e., both parties claiming ownership of the generated alliance 
output. Up front clarity about future IP division is also of crucial importance in order to 
secure investors. Shan and Song (1997) found that the number of patents acquired was 
one of the principal triggers for obtaining foreign equity investors. 
In the agricultural biotechnology sector there are fewer alliances and partnerships 
relative to the health biotech sector (see Bagchi-Sen et al., 2011). Bagchi-Sen et al. (2011) 
have explained this finding on the basis of the structure of the agrifood biotech industry, 
in which few big companies state a permanent threat of take-over that prevents smaller 
biotech firms from entering into alliances with them; as one of the CEOs of an agricul-
tural biotech SME in our sample stated, she would rather cooperate with other small com-
panies, research institutes and universities, or with a client, but not with the big competitors 
next door. Such a situation calls for a further stimulation of the open innovation process 
itself, by creating the trust necessary to enter into cooperations by providing clarity on 
the IP situation not only when entering the alliance but also during the alliance process 
itself. We therefore recommend policy makers to support innovation alliances by provid-
107Exploring the characteristics of innovation alliances
ing an infrastructure in which alliances can flourish. One way of doing this is by stimu-
lating the formation of cluster organizations that can function as innovation brokers that 
provide network formation-, demand articulation-, internationalization- and innovation 
process-support to their member companies (see also the baseline description in Omta 
and Fortuin, 2011); such organizations could also act as a go-between among alliance 
partners (Nooteboom, 1999a,b). As part of the innovation process support activities, they 
can organize special workshops for biotech SMEs on how to behave in an innovation alli-
ance successfully. In such workshops open innovation support tools, such as contractual 
arrangements and technology and IP mapping can be presented. Enhanced use of these 
collaborative support tools may also reduce the fear among many biotech SMEs of step-
ping into an alliance, because a lack of clarity regarding the future ownership of upcom-
ing results often destroys the necessary compliance level needed to bring the collaboration 
successfully to a close. 
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